Document Details
Form
Filing Date
Feb 3, 2022
Document Date
Feb 1, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Olema Oncology
Issuer
Olema Pharmaceuticals, Inc.
Filer
MYLES DAVID C.